These issues are being taken seriously. In the summer of 2020, I was invited – along with several other neuroscientists – to speak at a US National Academy joint committee convened to help establish regulatory and legal frameworks for research involving both organoids and chimeras (animals genetically modified to express specific human characteristics).
